SOLVE FSHD Portfolio Company Altay Therapeutics Closes $37 Million Series A Financing to Advance DX5057 for FSHD
Milestone follows nearly US$7 million in seed investment and strategic support from SOLVE FSHD VANCOUVER, British Columbia — SOLVE FSHD, a venture-philanthropy organization dedicated to accelerating therapies for faciosc
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.